{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:55:47Z","timestamp":1782262547659,"version":"3.54.5"},"reference-count":44,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":329,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1111\/ane.12313","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T21:58:12Z","timestamp":1490392692000},"page":"169-175","source":"Crossref","is-referenced-by-count":17,"title":["Insulin resistance in patients on valproic acid: relation to adiponectin"],"prefix":"10.1155","volume":"131","author":[{"given":"R. H.","family":"Aly","sequence":"first","affiliation":[{"name":"Department of Paediatrics; Faculty of Medicine; Ain Shams University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. H.","family":"Amr","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; Faculty of Medicine; Ain Shams University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. E.","family":"Saad","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology; Faculty of Medicine; Ain Shams University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Megahed","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; Faculty of Medicine; Ain Shams University; Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2014,10,7]]},"reference":[{"key":"10.1111\/ane.12313-BIB0001|ane12313-cit-0001","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1684\/ecn.2011.0284","article-title":"New adipocytokines (vaspin, apelin, visfatin, adiponectin) levels in children treated with valproic acid","volume":"22","author":"Meral","year":"2011","journal-title":"Eur Cytokine Netw"},{"key":"10.1111\/ane.12313-BIB0002|ane12313-cit-0002","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1059-1311(97)80065-9","article-title":"Weight gain with valproate or carbamazepine - a reappraisal","volume":"6","author":"Easter","year":"1997","journal-title":"Seizure"},{"key":"10.1111\/ane.12313-BIB0003|ane12313-cit-0003","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1053\/meta.2002.34708","article-title":"Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy","volume":"51","author":"Luef","year":"2002","journal-title":"Metabolism"},{"key":"10.1111\/ane.12313-BIB0004|ane12313-cit-0004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000197868","article-title":"Valproate induced insulin resistance and obesity in children","volume":"71","author":"Verrotti","year":"2009","journal-title":"Horm Res"},{"key":"10.1111\/ane.12313-BIB0005|ane12313-cit-0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1345\/aph.1L414","article-title":"Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy","volume":"43","author":"Grosso","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1111\/ane.12313-BIB0006|ane12313-cit-0006","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0317167100021879","article-title":"Weight gain in epileptic patient during treatment with valproic acid: a retrospective study","volume":"24","author":"Corman","year":"1997","journal-title":"Can J Neurol Sci"},{"key":"10.1111\/ane.12313-BIB0007|ane12313-cit-0007","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","article-title":"Serum insulin and leptin levels in valproate-associated obesity","volume":"43","author":"Pylvanen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12313-BIB0008|ane12313-cit-0008","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/ane.12313-BIB0009|ane12313-cit-0009","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2337\/diacare.26.8.2442","article-title":"Adiponectin: more than just another fat cell hormone?","volume":"26","author":"Chandran","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1111\/ane.12313-BIB0010|ane12313-cit-0010","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1203\/01.pdr.0000262638.48304.ef","article-title":"New predictors of the metabolic syndrome in children - role of adipocytokines","volume":"61","author":"Korner","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1111\/ane.12313-BIB0011|ane12313-cit-0011","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1212\/01.wnl.0000187074.27586.d1","article-title":"Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid","volume":"65","author":"Greco","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/ane.12313-BIB0012|ane12313-cit-0012","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on classification and terminology, 2005-2009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12313-BIB0013|ane12313-cit-0013","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","article-title":"Establishing a standard definition for child overweight and obesity worldwide: international survey","volume":"320","author":"Cole","year":"2000","journal-title":"BMJ"},{"key":"10.1111\/ane.12313-BIB0014|ane12313-cit-0014","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jnnp.54.10.873","article-title":"The chalfont seizure severity scale","volume":"54","author":"Duncan","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12313-BIB0015|ane12313-cit-0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/adc.51.3.170","article-title":"Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty","volume":"51","author":"Tanner","year":"1976","journal-title":"Arch Dis Child"},{"key":"10.1111\/ane.12313-BIB0016|ane12313-cit-0016","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/17477160903497043","article-title":"A three-country study on the components of the metabolic syndrome in youths: the BIG Study","volume":"5","author":"Schwandt","year":"2010","journal-title":"Int J Pediatr Obes"},{"key":"10.1111\/ane.12313-BIB0017|ane12313-cit-0017","doi-asserted-by":"crossref","unstructured":"Schwandt P Haas G-M 2012 Waist circumference in children and adolescents from different ethnicities, childhood obesity 10.5772\/17936 http:\/\/www.intechopen.com\/books\/childhood-obesity\/waist-circumference-in-children-and-adolescents-from-different-ethnicities","DOI":"10.5772\/17936"},{"key":"10.1111\/ane.12313-BIB0018|ane12313-cit-0018","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1515\/JPEM.2007.20.2.187","article-title":"Assessment of insulin sensitivity from measurements in fasting state and during an oral glucose tolerance test in obese children","volume":"20","author":"Atabek","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1111\/ane.12313-BIB0019|ane12313-cit-0019","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1111\/ane.12313-BIB0020|ane12313-cit-0020","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1158\/1535-7163.MCT-08-1076","article-title":"Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo","volume":"8","author":"Kortenhorst","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1111\/ane.12313-BIB0021|ane12313-cit-0021","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.56.2.172","article-title":"Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy","volume":"56","author":"Biton","year":"2001","journal-title":"Neurology"},{"key":"10.1111\/ane.12313-BIB0022|ane12313-cit-0022","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2165\/00002018-200124130-00004","article-title":"Bodyweight and anticonvulsants: a comparative review","volume":"24","author":"Jallon","year":"2001","journal-title":"Drug Saf"},{"key":"10.1111\/ane.12313-BIB0023|ane12313-cit-0023","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00381-012-1788-7","article-title":"Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic patients treated with valproate","volume":"28","author":"Tokgoz","year":"2012","journal-title":"Childs Nerv Syst"},{"key":"10.1111\/ane.12313-BIB0024|ane12313-cit-0024","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.53.1.230","article-title":"Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid","volume":"53","author":"Verrotti","year":"1999","journal-title":"Neurology"},{"key":"10.1111\/ane.12313-BIB0025|ane12313-cit-0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.yebeh.2006.02.008","article-title":"Insulin-related metabolic changes during treatment with valproate in patients with epilepsy","volume":"8","author":"Pylvanen","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12313-BIB0026|ane12313-cit-0026","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/08830738050200101501","article-title":"Serum insulin, leptin, and neuropeptide Y levels in epileptic children treated with valproate","volume":"20","author":"Aydin","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1111\/ane.12313-BIB0027|ane12313-cit-0027","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.seizure.2013.07.007","article-title":"The effects of topiramate and valproate on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy","volume":"22","author":"Sonmez","year":"2013","journal-title":"Seizure"},{"key":"10.1111\/ane.12313-BIB0028|ane12313-cit-0028","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.seizure.2012.05.001","article-title":"Valproate sodium enhances body weight gain in patients with childhood epilepsy: a Pathogenic mechanisms and open-label clinical trial of behavior therapy","volume":"21","author":"Kanemura","year":"2012","journal-title":"Seizure"},{"key":"10.1111\/ane.12313-BIB0029|ane12313-cit-0029","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00109-002-0378-7","article-title":"Adiponectin: a link between excess adiposity and associated comorbidities?","volume":"80","author":"Ukkola","year":"2002","journal-title":"J Mol Med"},{"key":"10.1111\/ane.12313-BIB0030|ane12313-cit-0030","first-page":"20","article-title":"Hypoadiponectinemia: a risk factor for metabolic syndrome","volume":"41","author":"Renaldi","year":"2009","journal-title":"Acta Med Indones"},{"key":"10.1111\/ane.12313-BIB0031|ane12313-cit-0031","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1542\/peds.103.3.588","article-title":"The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy","volume":"103","author":"Rattya","year":"1999","journal-title":"Pediatrics"},{"key":"10.1111\/ane.12313-BIB0032|ane12313-cit-0032","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1528-1167.2009.02206.x","article-title":"The metabolic syndrome in overweight epileptic patients treated with valproic acid","volume":"51","author":"Verotti","year":"2010","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12313-BIB0033|ane12313-cit-0033","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.410390506","article-title":"Obesity and endocrine disorders in women taking valproate for epilepsy","volume":"39","author":"Isojarvi","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1111\/ane.12313-BIB0034|ane12313-cit-0034","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/088307380201700405","article-title":"Insulin resistance in epileptic girls who gain weight after therapy with valproic acid","volume":"17","author":"Verrotti","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1111\/ane.12313-BIB0035|ane12313-cit-0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0887-8994(00)00133-8","article-title":"Weight gain associated with valproate in childhood","volume":"22","author":"Demir","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1111\/ane.12313-BIB0036|ane12313-cit-0036","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eplepsyres.2009.04.004","article-title":"Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment","volume":"86","author":"Luef","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12313-BIB0037|ane12313-cit-0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.52.1.1","article-title":"Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?","volume":"52","author":"Evans","year":"2003","journal-title":"Diabetes"},{"key":"10.1111\/ane.12313-BIB0038|ane12313-cit-0038","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0026-0495(92)90061-E","article-title":"Metabolic changes during treatment with valproate in humans: implication for untoward weight gain","volume":"41","author":"Breum","year":"1992","journal-title":"Metab, Clin Exp"},{"key":"10.1111\/ane.12313-BIB0039|ane12313-cit-0039","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1528-1167.2007.01460.x","article-title":"Adiponectin and visfatin concentrations in children treated with valproic acid","volume":"49","author":"Rauchenzauner","year":"2008","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12313-BIB0040|ane12313-cit-0040","first-page":"223","article-title":"Ghrelin and resistin levels in children with epilepsy on valproic acid","volume":"7","author":"Tomoum","year":"2009","journal-title":"J Pediatr Neurol"},{"key":"10.1111\/ane.12313-BIB0041|ane12313-cit-0041","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1262-3636(07)70167-2","article-title":"Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome","volume":"31","author":"Valle","year":"2005","journal-title":"Diabetes Metab"},{"key":"10.1111\/ane.12313-BIB0042|ane12313-cit-0042","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/00048670802534341","article-title":"Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls","volume":"43","author":"Elmslie","year":"2009","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1111\/ane.12313-BIB0043|ane12313-cit-0043","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.2337\/diabetes.54.6.1744","article-title":"C\/EBP alpha regulates human adiponectin gene expression through an intronic enhancer","volume":"54","author":"Qioa","year":"2005","journal-title":"Diabetes"},{"key":"10.1111\/ane.12313-BIB0044|ane12313-cit-0044","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2337\/diabetes.52.2.268","article-title":"Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin","volume":"52","author":"Combs","year":"2003","journal-title":"Diabetes"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12313","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12313","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12313\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:47:53Z","timestamp":1671540473000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,7]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12313","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10,7]]}}}